A 38-year-old woman with MDD was started on escitalopram 10 mg daily eight weeks ago. At her follow-up, her PHQ-9 score has decreased from 19 to 14. She reports some improvement in sleep and appetite but continues to feel sad and unmotivated most days. She tolerates the medication without side effects. Using a measurement-based care approach, what is the most appropriate next step?